Cerebral venous thrombosis is a rare but potentially life-threatening condition that is particularly prevalent in young women (ie, mean age 44 years) and accounts for 0·5–3% of all strokes. The ...

Endovascular Engineering (E2) announced today that it raised $42 million in an oversubscribed Series B financing round.

Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its n ...

Sweden: A recent study published in the Journal of Internal Medicine has highlighted an elevated risk of bleeding in patients with venous thromboembolism (VTE) undergoing treatment with direct oral ...

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

Ongoing trials in other indications, including treatment of VTE and stroke prevention in patients with atrial fibrillation, is where these new agents will probably demonstrate their greatest ...

Data sources: Published, randomized controlled trials (RCTs) of OAC treatment of VTE. Study selection: RCTs of varying durations of OAC treatment of VTE that include VTE recurrence (or extension ...

Considering taking supplements to treat venous thromboembolism vte? Below is a list of common natural remedies used to treat or reduce the symptoms of venous thromboembolism vte. Follow the links ...

"Endovascular Engineering secures $42m for clot removal technology platform" was originally created and published by Medical ...

Blood thinners prescribed after blood clots in the leg or lung initially increase the risk of bleeding, especially in women ...